The 1873 Comstock Act makes it a crime to mail abortion drugs or medicine – raising legal questions about the law’s potential revival and influence over nationwide abortion laws.
Academic rigour, journalistic flair
Articles on Mifepristone
Displaying all articles
As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.
Mifepristone’s safety in medication abortions has been well established over more than two decades, but legal wrangling leaves the future of the drug hanging in the balance.
The Supreme Court’s ruling on mifepristone keeps the drug accessible for now, but its future is still in limbo.
Many people wonder how courts can rule in contradictory ways. But it happens relatively frequently.
The increase in abortion restrictions may also lead to a decline in access to emergency contraceptives.
If the ruling to reverse the use of mifepristone stands, it will not only severely restrict abortion access for women throughout the US – it will have far-reaching effects on health care.
Mexico abortion referral networks are assisting American citizens and undocumented migrants seeking abortions. The model could provide inspiration for similar networks at the Canada-U.S. border.
A rash of pending lawsuits raises questions about the FDA’s approval of mifepristone two decades ago, whether the drug can be legally mailed and the constitutional right to interstate commerce.
The FDA’s allowance for pharmacies to dispense mifepristone will broaden access to the two-pill mifepristone-misoprostol regimen of medication abortion, which is 95% to 98% effective.
The fall of Roe v. Wade will result in more people deciding to privately end a pregnancy, a new study finds. But how often people will turn to safe versus unsafe options remains to be seen.
Abortion pills are available online, and many of them are safe. But not all sites have been properly vetted for legitimacy.
There will no doubt be escalating rhetoric from anti-choice politicians in the wake of the fall of Roe v Wade. An abortion care provider says now is the time to improve abortion access in Canada.
Pandemic-related travel restrictions and facility closures initially jeopardized access to abortions, but the pandemic has also become a catalyst for more accessible ways to deliver abortion care.
Some countries made abortion access easier during the pandemic. Others used it as an excuse for a crackdown.
The medical abortion drug mifepristone has been available in Australian for the past 13 years but it’s still out of reach for many women who decide to terminate their pregnancy.
Top contributors
-
Professor of Law, University of Virginia
-
Professor of law, George Washington University
-
Associate Professor of Family Medicine, School of Medicine, University of Washington
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
-
Associate Professor of Obstetrics, Gynecology and Gynecologic Surgery, University of California, San Francisco
-
Professor of Obstetrics and Gynaecology, James Cook University
-
Professor, School of Architecture, Syracuse University
-
Associate professor, Grenoble École de Management (GEM)
-
PhD, School of Nursing, Dalhousie University
-
Professor, Institute of Feminist and Gender Studies, L’Université d’Ottawa/University of Ottawa
-
Assistant professor, Kedge Business School
-
PhD Candidate, Reproductive and Developmental Sciences, University of British Columbia
-
Postdoctoral Fellow, Obstetrics and Gynaecology, University of British Columbia
-
Associate Professor of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco
-
Service Assistant Professor in Family Medicine, West Virginia University
